搜尋結果
CVS Health Profits Tumble To $1.1 Billion On Higher Costs To Treat Seniors
Forbes· 2 日前CVS Health reported first quarter profits were cut almost in half to $1.1 billion compared to ...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 12 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), ...
Walmart To Close Health Clinics In Latest Blow To Retail Healthcare
Forbes· 3 日前Walmart is closing its Walmart Health centers and virtual care business, saying it doesn’t see ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 2 小時前, opens new tab said on Thursday it was encouraged by the findings after completing an interim ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 18 小時前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
One personal decision can create a mess of financial challenges for transgender ...
CNBC· 6 小時前Changing their name may be an important step a transgender or nonbinary person takes to embrace ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 1 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...
How Crackers Went From Survival Food to Gourmet Treat
The Wall Street Journal· 6 日前Wondering how I could get some more, I found that on the Talbott & Arding website, these ...
Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
CNBC· 5 小時前Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — ...
How to save for retirement if your company doesn't offer a 401(k)
CNBC· 2 日前You have other tax-advantaged options available to save for the future, including individual ...